Aposcience
Austria - ViennaBiotechnology
Focus: Aposcience is an Austrian biotech company specializing in cytokine and growth factor-based therapeutic treatments. The company operates as a niche player in the regenerative/cell signaling space since its 2008 founding.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About Aposcience
AI assessmentNot HiringNo open roles listed right now. Follow Aposcience to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Phase 1/2
Clinical Trials (1)
NCT04277598A Study to Evaluate Safety and Efficacy of APO-2 at Three Different Doses in Patients With Diabetic Foot Ulcer
Phase 1/2Help build intelligence for Aposcience
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.